Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 0.46 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2861267 | 0.95 | SLC22A1 (0.50) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL16936119 | 0.95 | SLC22A1 (0.50) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL16936160 | 0.95 | SLC22A1 (0.50) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| Iodide SCHEMBL28492605 | 0.93 | DNM1 (0.48) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| Water SCHEMBL1396250 | 0.89 | SLC22A1 (0.40) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| Bromide SCHEMBL28543161 | 0.89 | DNM1 (0.43) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| Bromide SCHEMBL17180403 | 0.89 | ALDH1A1 (0.48) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| Bromide SCHEMBL2992549 | 0.88 | SLC22A1 (0.41) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| Iodide SCHEMBL9208016 | 0.87 | SLC22A1 (0.54) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL9117364 | 0.86 | TSHR (0.39) | DNM1SLC22A1ALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1362160-B1 | COMPOSITION AND METHOD FOR INHIBITION OF FORMATION OF GAS HYDRATES | BAKER HUGHES INC (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-1456134-A1 | DETOXIFICATION OF QUATERNARY ONIUM COMPOUNDS WITH POLYCARBOXYLATE CONTAINING COMPOUND | BAKER HUGHES INCORPORATED (US) | 2004-09-15 | — | — | EP | disclosed |
| EP-1362160-A1 | COMPOSITION AND METHOD FOR INHIBITION OF FORMATION OF GAS HYDRATES | BAKER HUGHES INCORPORATED (US) | 2003-11-19 | — | — | EP | disclosed |
| US-6620330-B2 | Removing pollutants from waste water streams | BAKER HUGHES INCORPORATED | 2003-09-16 | — | — | US | disclosed |
| US-20030146173-A1 | Detoxification of quaternary onium compounds with polycarboxylate-containing compound | BAKER HUGHES INCORPORATED | 2003-08-07 | — | — | US | disclosed |
| US-6596911-B2 | Providing a mixture comprising water and a hydrocarbon; and contacting with onium compound and amine salt for inhibiting the formation of the hydrocarbon hydrates | BAKER HUGHES INCORPORATION | 2003-07-22 | — | — | US | disclosed |
| WO-2003051781-A1 | DETOXIFICATION OF QUATERNARY ONIUM COMPOUNDS WITH POLYCARBOXYLATE CONTAINING COMPOUND | BAKER HUGHES INCORPORATED (US) | 2003-06-26 | — | — | WO | disclosed |
| WO-2002066785-A1 | COMPOSITION AND METHOD FOR INHIBITION OF FORMATION OF GAS HYDRATES | BAKER HUGHES INCORPORATED (US) | 2002-08-29 | — | — | WO | disclosed |
| US-20020038063-A1 | Composition and method for inhibition of formation of gas hydrates | BAKER HUGHES INCORPORATED | 2002-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020038063-A1 | Composition and method for inhibition of formation of gas hydrates | HDHD5, SHH, NOTUM | DNM1 1836/4885SLC22A1 2116/4885ALDH1A1 4272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.